UK markets close in 8 hours 9 minutes

Altamira Therapeutics Ltd. (CYTO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.4300-0.0600 (-4.03%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in CHF. All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
617.409
15.395
984.191
11,259
Total cash
617.409
15.395
984.191
11,259
Net receivables
0
6.525
21.746
0
Inventory
0
11.644
839.221
0
Total current assets
1,223
1,769
4,092
11,617
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
935.217
1,182
1,182
587.194
Accumulated depreciation
-855.106
-735.802
-616.915
-540.558
Net property, plant and equipment
80.111
445.828
564.715
46.636
Equity and other investments
2,497
194.263
199.105
20.001
Intangible assets
3,894
3,894
14,315
9,115
Other long-term assets
-
0.168
-
-
Total non-current assets
6,471
4,534
15,079
9,182
Total assets
7,694
6,303
19,170
20,799
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
5,870
-
523.92
Accounts payable
413.111
4,768
3,544
722.272
Accrued liabilities
158.231
1,615
851.658
1,331
Other current liabilities
-
-
-
310.439
Total current liabilities
888.914
12,880
4,861
3,030
Non-current liabilities
Deferred tax liabilities
0
125.87
142.484
125.865
Deferred revenues
0
932.2
0
-
Total non-current liabilities
346.628
1,738
1,274
999.559
Total liabilities
1,236
14,618
6,134
4,029
Stockholders' equity
Common stock
2.646
236.011
149.643
114.172
Retained earnings
-18,046
-201,431
-175,687
-160,636
Accumulated other comprehensive income
177.583
123.115
62.069
61.297
Total stockholders' equity
6,459
-8,315
13,036
16,770
Total liabilities and stockholders' equity
7,694
6,303
19,170
20,799